Advocating for LDL-C Measurement in Medicare Quality Programs: NLA's Urgent Call

The National Lipid Association (NLA), along with the Foundation of the National Lipid Association (FNLA), has made a significant appeal to the Centers for Medicare & Medicaid Services (CMS) and newly appointed Administrator Dr. Mehmet C. Oz. Their collective aim is to urge CMS to incorporate low-density lipoprotein cholesterol (LDL-C) measurement into its quality measurement programs. The heightened focus on LDL-C is essential as it plays a pivotal role in managing atherosclerotic cardiovascular disease (ASCVD), which is currently the leading cause of mortality in the United States.

For over ten years, there has been a troubling upward trend in ASCVD-related deaths in contrast to a previous 40-year decline. This alarming rise correlates with diminishing rates of LDL-C measurement among patients and a decline in CMS incentives designed to address the issue. Christie M. Ballantyne, MD and President of the NLA, emphasizes the critical nature of this situation by stating there is concrete evidence linking reduced LDL-C levels to a lower risk of ASCVD. He points out, however, that despite these guidelines from organizations like the American Heart Association (AHA) and the American College of Cardiology (ACC), many healthcare providers are falling short in proper LDL-C monitoring and management.

The established guidelines indicate the necessity for LDL-C measurements in patients diagnosed with ASCVD, particularly within 90 days following a hospitalization for myocardial infarction. Despite this, startling statistics reveal that only 29.9% of Medicare beneficiaries had their LDL-C tested post-hospitalization. Moreover, only 49.9% of patients with ASCVD are on any form of statin therapy. Given these figures, it becomes clear that significant gaps remain in the application of best practices in lipid management.

Dr. Ballantyne notes that the current quality measures often fall short by merely considering statin prescriptions rather than assessing patient adherence to therapy or the effectiveness of the medication. He states, "Existing measures fail to fully capture whether patients are actually taking their medication or if it's achieving the desired outcome."

Dr. James A. Underberg, President of the Foundation, reiterates the importance of revising quality measures to concentrate on both lipid measurement and management. He insists these measures could channel clinicians' focus towards better prevention of cardiovascular events, ultimately empowering patients to make informed health decisions. "Improving current quality measures to prioritize lipid management based on LDL-C levels will equip providers with vital information to better prevent cardiovascular complications," Underberg says.

The NLA and FNLA are optimistic about collaborating with CMS and Dr. Oz to foster evidence-based updates and quality improvements concerning LDL-C assessments. Their commitment to addressing the ASCVD crisis hinges on enhancing LDL-C management practices.

The National Lipid Association is a renowned nonprofit organization dedicated to advancing the science and treatment of lipidology. With over 2,200 members across the U.S., the NLA stands at the forefront of lipid management education and advocacy. They have been instrumental in developing comprehensive clinical guidelines for cholesterol management that align with cutting-edge research.

=====
About the National Lipid Association
The National Lipid Association focuses on advancing lipid science and clinical practices to promote optimal health outcomes. With a large membership engaged in research, education, and advocacy, the NLA provides critical resources that impact clinical practice and patient care across America. Visit www.lipid.org for more details.

About the Foundation of the National Lipid Association
The Foundation works to enhance the well-being of patients dealing with cholesterol management challenges. Through education and resource development, the Foundation plays a vital role in addressing issues that may increase the risk of severe health events, such as heart attacks or strokes. For more information, explore www.learnyourlipids.com.